Stijn L W Koolen - JoVE Visualize

Showing results (51-60 of 125) with videos related to

Pageof 13

Sort By:

Cancers|February 11, 2023

In Vivo Efficacy Testing of Peptide Receptor Radionuclide Therapy Radiosensitization Using OlaparibDanny Feijtel, Thom G A Reuvers, Christine van Tuyll-van Serooskerken, et al.

Journal of Pain and Symptom Management|August 30, 2024

Optimizing the Dosing Regimen During Rotation From Subcutaneous to Transdermal Administration of FentanylBram C Agema, Kim Vrielink, Esther Oomen-de Hoop, et al.

Therapeutic Advances in Medical Oncology|June 9, 2022

Improving the tolerability of osimertinib by identifying its toxic limitBram C Agema, G D Marijn Veerman, Christi M J Steendam, et al.

European Urology Oncology|November 4, 2023

Early Identification of Patients at Risk of Cabazitaxel-induced Severe NeutropeniaBram C Agema, Stefan A J Buck, Mano Viskil, et al.

Genes|April 2, 2020

Influence of Genetic Variation in <i>COMT</i> on Cisplatin-Induced Nephrotoxicity in Cancer PatientsBram C Agema, Stijn L W Koolen, Mirjam de With, et al.

Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2023

Influence of Food With Different Fat Concentrations on Alectinib Exposure: A Randomized Crossover Pharmacokinetic TrialDaan A C Lanser, Simon P de Leeuw, Esther Oomen-de Hoop, et al.

Clinical Pharmacokinetics|January 19, 2026

The Effect of Taking Cabozantinib with a Light Breakfast: A Randomized Crossover Pharmacokinetic Study (SKIPPY 1)Amy Rieborn, Niels A D Guchelaar, Teun van Gelder, et al.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 20, 2022

The influence of green tea extract on nintedanib's bioavailability in patients with pulmonary fibrosisG D Marijn Veerman, Sanne C van der Werff, Stijn L W Koolen, et al.

Cancers|November 18, 2018

Pharmacokinetics of Sublingually Delivered Fentanyl in Head and Neck Cancer Patients Treated with Curatively Aimed Chemo or BioradiotherapyEvelien J M Kuip, Wendy H Oldenmenger, Esther Oomen-de Hoop, et al.

Cancers|August 7, 2021

Docetaxel Skin Exposure and Micronucleation Contributes to Skin Toxicity Caused by CPC634Florence Atrafi, Ruben A G van Eerden, Stijn L W Koolen, et al.

Pageof 13

Showing results (51-60 of 125) with videos related to

Sort By:

Pageof 13

Cancers|February 11, 2023

In Vivo Efficacy Testing of Peptide Receptor Radionuclide Therapy Radiosensitization Using OlaparibDanny Feijtel, Thom G A Reuvers, Christine van Tuyll-van Serooskerken, et al.

Journal of Pain and Symptom Management|August 30, 2024

Optimizing the Dosing Regimen During Rotation From Subcutaneous to Transdermal Administration of FentanylBram C Agema, Kim Vrielink, Esther Oomen-de Hoop, et al.

Therapeutic Advances in Medical Oncology|June 9, 2022

Improving the tolerability of osimertinib by identifying its toxic limitBram C Agema, G D Marijn Veerman, Christi M J Steendam, et al.

European Urology Oncology|November 4, 2023

Early Identification of Patients at Risk of Cabazitaxel-induced Severe NeutropeniaBram C Agema, Stefan A J Buck, Mano Viskil, et al.

Genes|April 2, 2020

Influence of Genetic Variation in <i>COMT</i> on Cisplatin-Induced Nephrotoxicity in Cancer PatientsBram C Agema, Stijn L W Koolen, Mirjam de With, et al.

Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2023

Influence of Food With Different Fat Concentrations on Alectinib Exposure: A Randomized Crossover Pharmacokinetic TrialDaan A C Lanser, Simon P de Leeuw, Esther Oomen-de Hoop, et al.

Clinical Pharmacokinetics|January 19, 2026

The Effect of Taking Cabozantinib with a Light Breakfast: A Randomized Crossover Pharmacokinetic Study (SKIPPY 1)Amy Rieborn, Niels A D Guchelaar, Teun van Gelder, et al.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 20, 2022

The influence of green tea extract on nintedanib's bioavailability in patients with pulmonary fibrosisG D Marijn Veerman, Sanne C van der Werff, Stijn L W Koolen, et al.

Cancers|November 18, 2018

Pharmacokinetics of Sublingually Delivered Fentanyl in Head and Neck Cancer Patients Treated with Curatively Aimed Chemo or BioradiotherapyEvelien J M Kuip, Wendy H Oldenmenger, Esther Oomen-de Hoop, et al.

Cancers|August 7, 2021

Docetaxel Skin Exposure and Micronucleation Contributes to Skin Toxicity Caused by CPC634Florence Atrafi, Ruben A G van Eerden, Stijn L W Koolen, et al.

Pageof 13